News

New Nomograms Predict Lymphedema After Axillary Lymph Node Dissection


 

FROM A BREAST CANCER SYMPOSIUM SPONSORED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Dr. Bevilacqua reported that he had no relevant conflicts of interest.

Pages

Recommended Reading

Vemurafenib Will Open Floodgates for Melanoma Genotyping
MDedge Hematology and Oncology
MULTIMEDIA: Vemurafenib -- Melanoma Drug Cuts Death Risk
MDedge Hematology and Oncology
Uncertainty Rules Adjuvant Chemo for Early HER2 Breast Cancer
MDedge Hematology and Oncology
Cancer Stage Not a Significant Factor in Radioiodine Use
MDedge Hematology and Oncology
Smoking-Bladder Cancer Link Strengthened - Especially in Women
MDedge Hematology and Oncology
ATHENA: HPV Testing Outperforms Cytology for Cervical Cancer Screening
MDedge Hematology and Oncology
NSCLC: FDA Approves Crizotinib, Companion Diagnostic Test
MDedge Hematology and Oncology
New Diarrheal Syndrome Tied to Cord-Blood Transplants
MDedge Hematology and Oncology
Crizotinib Approval Personalizes Lung Cancer Therapy
MDedge Hematology and Oncology
Study Supports Palpation, Mammography Regardless of Age
MDedge Hematology and Oncology